ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

RFPs Available, NIH Funding Strategies

February 18, 1994

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

NSABP Executive Committee Is Seeking Applications From Surgeons to Lead Group

July 29, 1994

Carcinogenesis, Epidemiology, Smoking RFAs Get DCCP Board Okay

June 12, 1981